United States Biotechnology & Medical Research

Personalis Inc (PSNL)

Track

Over the past 90 days, Personalis Inc. insiders have executed 17 transactions, all of which were sales totaling approximately $13.8 million. Key executives, including the CEO, CFO, and CMO, have consistently sold shares. These transactions occurred amid a 108.1% stock price increase, following the company's most recent results financiers report in May.
Ticker: PSNL Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Personalis Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Planned sale 15 Jul 2026
Value US$919,482.95 | Price 345.61 | Shares 75,781 (+35.2%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-15 2026-07-15 PlS Planned sale
3.1
Chen Richard

President and CMO

Officer
75,781 +35.2%
345.61
US$919,483 		75,781 +35.2% 345.61 US$919,483
2026-07-15 2026-07-15 PrS Proposed sale
3.1
RICHARD CHEN

Officer

Officer
7,348
245.33
US$668,742 		7,348 245.33 US$668,742
2026-07-09 2026-07-09 PlS Planned sale
2.6
Hall Christopher M

Chief Executive Officer

Executive Director
611 -28.5%
361.24
US$4,016,242 		611 -28.5% 361.24 US$4,016,242
2026-07-09 2026-07-09 PrS Proposed sale
2.6
Chris Hall

Director; Officer

Executive Director
100,000
14.11
US$1,411,000 		100,000 14.11 US$1,411,000
2026-06-29 2026-06-29 PlS Planned sale
3.4
Tachibana Aaron

CFO AND COO

Officer
4,982 -2.4%
14.00
US$69,748 		4,982 -2.4% 14.00 US$69,748
2026-06-29 2026-06-29 PrS Proposed sale
3.4
AARON TACHIBANA

Officer

Officer
4,982
13.02
US$64,866 		4,982 13.02 US$64,866
2026-06-26 2026-06-26 PlS Planned sale
3.4
Tachibana Aaron

CFO AND COO

Officer
51,251 -20.5%
13.18
US$675,488 		51,251 -20.5% 13.18 US$675,488
2026-06-26 2026-06-26 PlS Planned sale
2.6
Hall Christopher M

Chief Executive Officer

Executive Director
100,000 -29.8%
13.15
US$1,315,000 		100,000 -29.8% 13.15 US$1,315,000
2026-06-26 2026-06-26 PrS Proposed sale
3.4
AARON TACHIBANA

Officer

Officer
51,251
12.59
US$645,250 		51,251 12.59 US$645,250
2026-06-26 2026-06-26 PrS Proposed sale
2.6
Chris Hall

Director; Officer

Executive Director
100,000
12.59
US$1,259,000 		100,000 12.59 US$1,259,000
2026-06-05 2026-06-04 PlS Planned sale
3.4
Tachibana Aaron

CFO AND COO

Officer
40,000 -16.7%
12.01
US$480,400 		40,000 -16.7% 12.01 US$480,400
2026-06-04 2026-06-04 PrS Proposed sale
3.4
AARON TACHIBANA

Officer

Officer
40,000
10.78
US$431,200 		40,000 10.78 US$431,200
2026-05-29 2026-05-29 PlS Planned sale
2.6
Hall Christopher M

Chief Executive Officer

Executive Director
80,091 -25.3%
11.02
US$882,603 		80,091 -25.3% 11.02 US$882,603
2026-05-29 2026-05-29 PlS Planned sale
3.4
Tachibana Aaron

CFO AND COO

Officer
38,799 -16.3%
11.58
US$449,292 		38,799 -16.3% 11.58 US$449,292
2026-05-29 2026-05-29 PrS Proposed sale
3.4
AARON TACHIBANA

Officer

Officer
38,799
10.98
US$426,013 		38,799 10.98 US$426,013
2026-05-29 2026-05-28 PlS Planned sale
2.6
Hall Christopher M

Chief Executive Officer

Executive Director
19,909 -7.8%
11.02
US$219,397 		19,909 -7.8% 11.02 US$219,397
2026-05-28 2026-05-28 PrS Proposed sale
2.6
CHRISTOPHER HALL

Director; Officer

Executive Director
100,000
9.49
US$949,000 		100,000 9.49 US$949,000
2026-01-23 2026-01-22 PlS Planned sale
3.4
Tachibana Aaron

CFO AND COO

Officer
1,201 -0.7%
11.50
US$13,812 		1,201 -0.7% 11.50 US$13,812
2026-01-22 2026-01-22 PrS Proposed sale
3.4
AARON L TACHIBANA

Officer

Officer
40,000
9.65
US$386,000 		40,000 9.65 US$386,000
2026-02-13 2025-12-22 B Purchase
2.2
Tempus AI, Inc.
Large shareholder
28,000 +0.2%
8.93
US$250,040 		28,000 +0.2% 8.93 US$250,040
2026-02-13 2025-12-19 B Purchase
2.2
Tempus AI, Inc.
Large shareholder
29,641 +0.2%
8.39
US$248,688 		29,641 +0.2% 8.39 US$248,688
2026-02-13 2025-12-18 B Purchase
2.2
Tempus AI, Inc.
Large shareholder
31,430 +0.2%
7.91
US$248,611 		31,430 +0.2% 7.91 US$248,611
2026-02-13 2025-12-17 B Purchase
2.2
Tempus AI, Inc.
Large shareholder
31,650 +0.2%
7.86
US$248,769 		31,650 +0.2% 7.86 US$248,769
2026-02-13 2025-11-25 B Purchase
2.2
Tempus AI, Inc.
Large shareholder
13,888 +0.1%
11.00
US$152,768 		13,888 +0.1% 11.00 US$152,768
2026-02-13 2025-11-25 B Purchase
2.2
Tempus AI, Inc.
Large shareholder
9,712 +0.1%
10.08
US$97,897 		9,712 +0.1% 10.08 US$97,897
2025-11-28 2025-11-25 PlS Planned sale
3.4
Tachibana Aaron

CFO AND COO

Officer
103,668 -38.7%
10.78
US$1,117,541 		103,668 -38.7% 10.78 US$1,117,541
2025-11-25 2025-11-25 PrS Proposed sale
3.4
AARON L TACHIBANA

Officer

Officer
103,668
9.99
US$1,035,643 		103,668 9.99 US$1,035,643
2026-02-13 2025-11-24 B Purchase
2.2
Tempus AI, Inc.
Large shareholder
25,225 +0.2%
9.87
US$248,971 		25,225 +0.2% 9.87 US$248,971
2026-02-13 2025-11-21 B Purchase
2.2
Tempus AI, Inc.
Large shareholder
16,599 +0.1%
9.74
US$161,674 		16,599 +0.1% 9.74 US$161,674
2026-02-13 2025-11-21 B Purchase
2.2
Tempus AI, Inc.
Large shareholder
9,900 +0.1%
8.84
US$87,516 		9,900 +0.1% 8.84 US$87,516
2026-02-13 2025-11-20 B Purchase
2.2
Tempus AI, Inc.
Large shareholder
28,827 +0.2%
8.63
US$248,777 		28,827 +0.2% 8.63 US$248,777
2026-02-13 2025-11-19 B Purchase
2.2
Tempus AI, Inc.
Large shareholder
30,645 +0.2%
8.12
US$248,837 		30,645 +0.2% 8.12 US$248,837
2026-02-13 2025-11-18 B Purchase
2.2
Tempus AI, Inc.
Large shareholder
64,750 +0.5%
7.67
US$496,632 		64,750 +0.5% 7.67 US$496,632
2025-11-05 2025-11-03 S Sale
2.6
Hall Christopher M

PRESIDENT AND CEO

Executive Director
29,612 -16.6%
8.99
US$266,212 		29,612 -16.6% 8.99 US$266,212
2025-07-30 2025-07-28 S Sale
3.4
Tachibana Aaron

CFO AND COO

Officer
641 -0.4%
6.57
US$4,211 		641 -0.4% 6.57 US$4,211
2025-07-30 2025-07-28 S Sale
3.1
Chen Richard

CHIEF MEDICAL OFFICER AND EVP

Officer
452 -0.4%
6.57
US$2,970 		452 -0.4% 6.57 US$2,970
2025-05-20 2025-05-16 PlS Planned sale
3.1
Chen Richard

CHIEF MEDICAL OFFICER AND EVP

Officer
910 -0.7%
4.95
US$4,504 		910 -0.7% 4.95 US$4,504
2025-05-20 2025-05-16 S Sale
3.4
Tachibana Aaron

CFO AND COO

Officer
1,291 -0.8%
4.95
US$6,390 		1,291 -0.8% 4.95 US$6,390
2025-05-20 2025-05-16 S Sale
3.0
Moore Stephen Michael

SVP and Chief Legal Officer

Officer
1,675 -2.5%
4.95
US$8,291 		1,675 -2.5% 4.95 US$8,291
2025-01-30 2025-01-28 S Sale
3.4
Tachibana Aaron

CFO AND COO

Officer
708 -0.4%
5.79
US$4,099 		708 -0.4% 5.79 US$4,099
2025-01-30 2025-01-28 S Sale
3.1
Chen Richard

CHIEF MEDICAL OFFICER AND EVP

Officer
519 -0.4%
5.79
US$3,005 		519 -0.4% 5.79 US$3,005
2024-12-18 2024-12-16 S Sale
3.1
Chen Richard

CHIEF MEDICAL OFFICER AND EVP

Officer
4,834 -3.8%
3.82
US$18,466 		4,834 -3.8% 3.82 US$18,466
2024-12-18 2024-12-16 S Sale
3.0
Moore Stephen Michael

SVP and Chief Legal Officer

Officer
1,513 -2.2%
3.82
US$5,780 		1,513 -2.2% 3.82 US$5,780
2024-12-18 2024-12-16 S Sale
3.4
Tachibana Aaron

CFO AND COO

Officer
6,865 -3.9%
3.82
US$26,224 		6,865 -3.9% 3.82 US$26,224
2024-11-20 2024-11-18 S Sale
3.0
Moore Stephen Michael

SVP and Chief Legal Officer

Officer
1,693 -2.5%
3.79
US$6,416 		1,693 -2.5% 3.79 US$6,416
2024-11-20 2024-11-18 PlS Planned sale
3.1
Chen Richard

CHIEF MEDICAL OFFICER AND EVP

Officer
921 -0.7%
3.79
US$3,491 		921 -0.7% 3.79 US$3,491
2024-11-20 2024-11-18 S Sale
3.4
Tachibana Aaron

CFO AND COO

Officer
1,307 -0.7%
3.79
US$4,954 		1,307 -0.7% 3.79 US$4,954
2024-11-05 2024-11-01 S Sale
2.6
Hall Christopher M

PRESIDENT AND CEO

Executive Director
26,443 -12.9%
5.38
US$142,263 		26,443 -12.9% 5.38 US$142,263
2024-08-20 2024-08-16 B Purchase
2.2
Tempus AI, Inc.
Large shareholder
3,500,000 +38.0%
5.07
US$17,745,000 		3,500,000 +38.0% 5.07 US$17,745,000
2024-08-01 2024-07-30 S Sale
3.1
Chen Richard

CHIEF MEDICAL OFFICER AND EVP

Officer
524 -0.4%
2.97
US$1,556 		524 -0.4% 2.97 US$1,556
2024-08-01 2024-07-30 S Sale
3.4
Tachibana Aaron

CFO AND COO

Officer
742 -0.4%
2.97
US$2,204 		742 -0.4% 2.97 US$2,204
2024-06-20 2024-06-17 S Sale
3.0
Moore Stephen Michael

SVP and Chief Legal Officer

Officer
1,585 -2.2%
1.29
US$2,045 		1,585 -2.2% 1.29 US$2,045
2024-06-20 2024-06-17 S Sale
3.1
Chen Richard

CHIEF MEDICAL OFFICER AND EVP

Officer
5,055 -3.8%
1.29
US$6,521 		5,055 -3.8% 1.29 US$6,521
2024-06-20 2024-06-17 S Sale
3.4
Tachibana Aaron

CFO AND COO

Officer
7,176 -3.9%
1.29
US$9,257 		7,176 -3.9% 1.29 US$9,257
2024-05-21 2024-05-17 S Sale
3.4
Tachibana Aaron

CFO AND COO

Officer
1,333 -0.7%
1.38
US$1,840 		1,333 -0.7% 1.38 US$1,840
2024-05-21 2024-05-17 PlS Planned sale
3.1
Chen Richard

CHIEF MEDICAL OFFICER AND EVP

Officer
940 -0.7%
1.38
US$1,297 		940 -0.7% 1.38 US$1,297
2024-05-21 2024-05-17 S Sale
3.0
Moore Stephen Michael

SVP and Chief Legal Officer

Officer
1,731 -2.4%
1.38
US$2,389 		1,731 -2.4% 1.38 US$2,389
2024-05-21 2024-05-17 S Sale
3.0
Moore Stephen Michael

SVP and Chief Legal Officer

Officer
1,731 -2.4%
1.38
US$2,389 		1,731 -2.4% 1.38 US$2,389
2024-05-02 2024-04-30 S Sale
3.0
Moore Stephen Michael

SVP and Chief Legal Officer

Officer
4,523 -5.9%
1.37
US$6,197 		4,523 -5.9% 1.37 US$6,197
2024-03-05 2024-03-01 B Purchase
0.6
MYERS WOODROW A JR
Non-Executive Director
10,000 +62.1%
1.67
US$16,700 		10,000 +62.1% 1.67 US$16,700
2024-01-31 2024-01-29 S Sale
3.1
Chen Richard

CHIEF MEDICAL OFFICER AND EVP

Officer
526 -0.4%
1.37
US$721 		526 -0.4% 1.37 US$721
2024-01-31 2024-01-29 S Sale
3.4
Tachibana Aaron

CFO AND COO

Officer
716 -0.4%
1.37
US$981 		716 -0.4% 1.37 US$981
2023-12-19 2023-12-15 PlS Planned sale
3.1
Chen Richard

Chief Medical Officer and EVP

Officer
4,708 -3.5%
1.47
US$6,921 		4,708 -3.5% 1.47 US$6,921
2023-12-19 2023-12-15 S Sale
3.4
Tachibana Aaron

CFO and COO

Officer
6,747 -3.5%
1.47
US$9,918 		6,747 -3.5% 1.47 US$9,918
2023-12-19 2023-12-15 S Sale
3.0
Moore Stephen Michael

General Counsel

Officer
1,476 -1.9%
1.47
US$2,170 		1,476 -1.9% 1.47 US$2,170
2023-11-20 2023-11-16 S Sale
3.4
Tachibana Aaron

CFO and COO

Officer
1,344 -0.7%
1.04
US$1,398 		1,344 -0.7% 1.04 US$1,398
2023-11-20 2023-11-16 S Sale
3.1
Chen Richard

Chief Medical Officer and EVP

Officer
940 -0.8%
1.04
US$978 		940 -0.8% 1.04 US$978
2023-11-20 2023-11-16 S Sale
3.0
Moore Stephen Michael

General Counsel

Officer
1,722 -2.1%
1.04
US$1,791 		1,722 -2.1% 1.04 US$1,791
2023-11-03 2023-11-01 S Sale
2.6
Hall Christopher M

President and CEO

Executive Director
20,459 -9.1%
0.93
US$19,027 		20,459 -9.1% 0.93 US$19,027
2023-08-02 2023-07-31 S Sale
3.1
Chen Richard

Chief Medical Officer and EVP

Officer
485 -0.4%
2.26
US$1,096 		485 -0.4% 2.26 US$1,096
2023-08-02 2023-07-31 S Sale
3.4
Tachibana Aaron

CFO and COO

Officer
662 -0.3%
2.26
US$1,496 		662 -0.3% 2.26 US$1,496
2023-06-21 2023-06-16 S Sale
3.1
Chen Richard

Chief Medical Officer and EVP

Officer
4,817 -3.7%
2.07
US$9,971 		4,817 -3.7% 2.07 US$9,971
2023-06-21 2023-06-16 S Sale
3.4
Tachibana Aaron

CFO and COO

Officer
6,904 -3.4%
2.07
US$14,291 		6,904 -3.4% 2.07 US$14,291
2023-06-21 2023-06-16 S Sale
3.0
Moore Stephen Michael

General Counsel

Officer
1,509 -1.8%
2.07
US$3,124 		1,509 -1.8% 2.07 US$3,124
2023-05-19 2023-05-17 S Sale
3.1
Chen Richard

Chief Medical Officer and EVP

Officer
971 -0.7%
1.98
US$1,923 		971 -0.7% 1.98 US$1,923
Explore more

More insider trading research around Personalis Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America